Evidence map›Paper›PMID 33420346›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2021

Biallelic UBE4A loss-of-function variants cause intellectual disability and global developmental delay.

Uirá Souto Melo, Devon Bonner, Kevin C Kent Lloyd, Ala Moshiri, Brandon Willis, Louise Lanoue, Lynette Bower, Brian C Leonard, Davi Jardim Martins, Fernando Gomes and 18 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 7 institutions in 5 countries.

Uirá Souto Melo *Human Genome and Stem Cell Research Center, Department of Genetics and Evolutionary Biology, Biosciences Institute, University of São Paulo (USP), São Paulo, SP, Brazil. umelo@molgen.mpg.de.ORCID http://orcid.org/0000-0003-4065-8635
Devon Bonner *Division of Medical Genetics, Department of Pediatric, Stanford University School of Medicine, Stanford, CA, USA.
Kevin C Kent LloydMouse Biology Program, University of California-Davis, Davis, CA, USA.
Ala MoshiriDepartment of Ophthalmology & Vision Science, School of Medicine, University of California Davis, Sacramento, CA, USA.
Brandon WillisMouse Biology Program, University of California-Davis, Davis, CA, USA.
Louise LanoueMouse Biology Program, University of California-Davis, Davis, CA, USA.
Lynette BowerMouse Biology Program, University of California-Davis, Davis, CA, USA.
Brian C LeonardDepartment of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California-Davis, Davis, CA, USA.
Davi Jardim MartinsDepartment of Microbiology, Institute of Biomedical Sciences, University of São Paulo (USP), São Paulo, SP, Brazil.
Fernando GomesHuman Genome and Stem Cell Research Center, Department of Genetics and Evolutionary Biology, Biosciences Institute, University of São Paulo (USP), São Paulo, SP, Brazil.
Felipe de Souza LeiteHuman Genome and Stem Cell Research Center, Department of Genetics and Evolutionary Biology, Biosciences Institute, University of São Paulo (USP), São Paulo, SP, Brazil.
Danyllo OliveiraHuman Genome and Stem Cell Research Center, Department of Genetics and Evolutionary Biology, Biosciences Institute, University of São Paulo (USP), São Paulo, SP, Brazil.
João Paulo KitajimaMendelics, São Paulo, SP, Brazil.
Fabiola P MonteiroMendelics, São Paulo, SP, Brazil.
Mayana ZatzHuman Genome and Stem Cell Research Center, Department of Genetics and Evolutionary Biology, Biosciences Institute, University of São Paulo (USP), São Paulo, SP, Brazil.
Carlos Frederico Martins MenckDepartment of Microbiology, Institute of Biomedical Sciences, University of São Paulo (USP), São Paulo, SP, Brazil.
Matthew T WheelerDivision of Cardiovascular Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Jonathan A BernsteinDivision of Medical Genetics, Department of Pediatric, Stanford University School of Medicine, Stanford, CA, USA.
Kevin DumasClinical Genomics Program, Department of Pathology, School of Medicine, Stanford University, Stanford, CA, USA.
Elizabeth SpiteriClinical Genomics Program, Department of Pathology, School of Medicine, Stanford University, Stanford, CA, USA.
Nataliya Di DonatoInstitute for Clinical Genetics, Technische Universität Dresden, Dresden, Germany.
Arne JahnInstitute for Clinical Genetics, Technische Universität Dresden, Dresden, Germany.
Mais HashemDepartment of Genetics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Hessa S AlsaifDepartment of Genetics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Aziza ChedrawiDepartment of Neuroscience, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Fowzan S AlkurayaDepartment of Genetics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Fernando KokHuman Genome and Stem Cell Research Center, Department of Genetics and Evolutionary Biology, Biosciences Institute, University of São Paulo (USP), São Paulo, SP, Brazil.
Heather M ByersDivision of Medical Genetics, Department of Pediatric, Stanford University School of Medicine, Stanford, CA, USA. hbyers@stanford.edu.
Universidade de São Paulo · BRStanford University · USUniversity of California, Davis · USKing Faisal Specialist Hospital & Research Centre · SAMendelics · BRTechnische Universität Dresden · DEAlfaisal University · SA

Funding

UCD Mutant Mouse Regional Resource CenterU42OD012210 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KC KENT LLOYD · 2012 to 2026
$29.2M
NIH HHS U42 OD012210
6 · The paper itself

Abstract

purposeTo identify novel genes associated with intellectual disability (ID) in four unrelated families.

methodsHere, through exome sequencing and international collaboration, we report eight individuals from four unrelated families of diverse geographic origin with biallelic loss-of-function variants in UBE4A.

resultsEight evaluated individuals presented with syndromic intellectual disability and global developmental delay. Other clinical features included hypotonia, short stature, seizures, and behavior disorder. Characteristic features were appreciated in some individuals but not all; in some cases, features became more apparent with age. We demonstrated that UBE4A loss-of-function variants reduced RNA expression and protein levels in clinical samples. Mice generated to mimic patient-specific Ube4a loss-of-function variant exhibited muscular and neurological/behavioral abnormalities, some of which are suggestive of the clinical abnormalities seen in the affected individuals.

conclusionThese data indicate that biallelic loss-of-function variants in UBE4A cause a novel intellectual disability syndrome, suggesting that UBE4A enzyme activity is required for normal development and neurological function.

Indexed as

DwarfismIntellectual DisabilityAnimalsChildDevelopmental DisabilitiesExome SequencingHumansMiceMuscle HypotoniaPhenotypeSyndromeUbiquitin-Protein LigasesUBE4A protein, humanUbiquitin-Protein Ligases

Identifiers

PMID33420346
OpenAlexW3119304807

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.